Dawnrays Pharmaceutical (Holdings) Limited carries a market capitalization of 1.58B, placing it among publicly traded companies globally.
| Market Cap | 1.58B |
| Enterprise Value | N/A |
Dawnrays Pharmaceutical (Holdings) Limited's stock has declined approximately -14.63415% over the past 52 weeks. The 50-day moving average sits at 1.12, while the 200-day moving average is 1.18.
| Beta (5Y) | N/A |
| 52-Week Price Change | -14.63415% |
| 50-Day Moving Average | 1.12 |
| 200-Day Moving Average | 1.18 |
| Average Volume (20 Days) | N/A |
Dawnrays Pharmaceutical (Holdings) Limited's most recent stock split took place on August 6, 2018 with a 1:2 split ratio.
| Last Split Date | 8/6/2018 |
| Split Ratio | 1:2 |